ID

29931

Descrição

Study ID: 102123 Clinical Study ID: FFR102123 Study Title: A randomised double-blind placebo controlled parallel group multicentre long term study to evaluate the safety of once-daily, intranasal administration of GW685698X aqueous nasal spray 100mcg* for 52 weeks in adult and adolescent subjects with perennial allergic rhinitis. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate Trade Name: FLUTIDE, Allermist, Veramyst, FLUNASE, FLIXOTAIDE, FLUTAIDE, FLIXOVATE, Avamys; Veramyst, Avamys, Allermist Study Indication: Rhinitis, Allergic, Perennial This ODM-file contains Repeat 12-lead-ECG.

Palavras-chave

Versões (1)
  1. 27/04/2018 27/04/2018 - Sarah Riepenhausen
Titular dos direitos

GlaxoSmithKline

Transferido a

27 de abril de 2018

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Safety of once-daily administration of Fluticasone nasal spray in adults and adolescents with perennial allergic rhinitis GSK 102123

Inglês

Repeat 12-lead-ECG

1 Formulários  
  1. StudyEvent: ODM
    1. Repeat 12-lead-ECG
12-Lead ECG Repeat
Descrição

12-Lead ECG Repeat

Alias
UMLS CUI-1
C0430456
UMLS CUI-2
C0205341
Date of ECG
Descrição

Date of ECG

Tipo de dados

date

Alias
UMLS CUI [1,1]
C0430456
UMLS CUI [1,2]
C0205341
UMLS CUI [1,3]
C0011008
Time of ECG
Descrição

Time of ECG

Tipo de dados

time

Alias
UMLS CUI [1,1]
C0430456
UMLS CUI [1,2]
C0205341
UMLS CUI [1,3]
C0040223
Result of ECG
Descrição

ECG must be repeated should any clinically significant abnormality/worsening be noted by the investigator post-randomisation or the ECG is flagged as unreadable by the central independent cardiologist. If the original ECG at Visit 1 is classified as ’abnormal, clinically significant’, the subject should not be randomised - even if a repeat ECG is ’normal’ or ’abnormal, clinically insignificant’." Complete the Non-Serious Adverse Events (AE) or Serious Adverse Event (SAE) page(s) if clinically significant abnormalities meet the protocol definition for an AE or SAE.

Tipo de dados

integer

Alias
UMLS CUI [1,1]
C0430456
UMLS CUI [1,2]
C0205341
UMLS CUI [1,3]
C1274040
Change in ECG result
Descrição

Complete the Non-Serious Adverse Events (AE) or Serious Adverse Event (SAE) page(s) if clinically significant abnormalities meet the protocol definition for an AE or SAE.

Tipo de dados

integer

Alias
UMLS CUI [1,1]
C0430456
UMLS CUI [1,2]
C1274040
UMLS CUI [1,3]
C0392747
Voltar ao início da página

Similar models

Repeat 12-lead-ECG

1 Formulários
  1. StudyEvent: ODM
    1. Repeat 12-lead-ECG
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
12-Lead ECG Repeat
C0430456 (UMLS CUI-1)
C0205341 (UMLS CUI-2)
Date of ECG
Item
Date of ECG
date
C0430456 (UMLS CUI [1,1])
C0205341 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Time of ECG
Item
Time of ECG
time
C0430456 (UMLS CUI [1,1])
C0205341 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
Item
Result of ECG
integer
C0430456 (UMLS CUI [1,1])
C0205341 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
ECG Results
Code List
Result of ECG
CL Item
Normal (1)
CL Item
Abnormal - not clinically significant (2)
CL Item
Abnormal - clinically significant (3)
Item
Change in ECG result
integer
C0430456 (UMLS CUI [1,1])
C1274040 (UMLS CUI [1,2])
C0392747 (UMLS CUI [1,3])
Change in ECG result
Code List
Change in ECG result
CL Item
Clinically significant change from baseline - favourable (1)
CL Item
Clinically significant change from baseline - unfavourable (2)
CL Item
No change or insignificant change from baseline (3)
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial